Back to mobile site

BMO Capital Reiterates Market Perform Rating on Merck (MRK) Following Earnings

February 3, 2022 7:46 AM EST Send to a Friend
BMO Capital analyst Evan David Seigerman reiterated a Market Perform rating and $87.00 price target on Merck (NYSE: MRK), following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login